Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year

1989

Stage

IPO | IPO

Total Raised

$28.62M

Date of IPO

3/25/1992

About Cytotherapeutics

Developer of cell encapsulation and transplantation technology for therapeutic applications. The company's technology is based on encapsulation research conducted at Brown University and pancreas islet cell isolation research conducted at Washington University in St. Louis. The company's first product consists of dopamine-secreting encapsulated mouse cells for treating Parkinson's disease. The second product is encapsulated porcine pancreatic islet cells for treating insulin-dependent diabetes.

Cytotherapeutics Headquarter Location

Two Richmond Square

Providence, Rhode Island, 02906,

United States

(401)272-3310

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cytotherapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cytotherapeutics is included in 1 Expert Collection, including Diabetes.

D

Diabetes

1,734 items

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.